In addition, for the HLA class I-A2+ individuals, we also assessed the ability of the CD8+ T cells to recognise autoantigenic peptides, presented by HLA-A2–peptide tetramers (n = 5 for healthy donors, 7 for slow progressors, 9 for newly diagnosed diabetes and 10 for long-standing diabetes). This evidence concerns the gene CD8A and diabetes mellitus.